Research ArticleArticle
Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis–Related Fibrosis in a Dietary Rat Model
Rieko Shimozono, Yoshiji Asaoka, Yoshitaka Yoshizawa, Takumi Aoki, Hidetoshi Noda, Masateru Yamada, Mie Kaino and Hidenori Mochizuki
Molecular Pharmacology July 2013, 84 (1) 62-70; DOI: https://doi.org/10.1124/mol.112.084269
Rieko Shimozono
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Yoshiji Asaoka
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Yoshitaka Yoshizawa
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Takumi Aoki
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Hidetoshi Noda
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Masateru Yamada
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Mie Kaino
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Hidenori Mochizuki
Toray Industries, Inc., Pharmaceutical Research Laboratories, Kanagawa, Japan
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Nrf2 Activators Attenuate Fibrosis Progression in NASH Model
Rieko Shimozono, Yoshiji Asaoka, Yoshitaka Yoshizawa, Takumi Aoki, Hidetoshi Noda, Masateru Yamada, Mie Kaino and Hidenori Mochizuki
Molecular Pharmacology July 1, 2013, 84 (1) 62-70; DOI: https://doi.org/10.1124/mol.112.084269
Research ArticleArticle
Nrf2 Activators Attenuate Fibrosis Progression in NASH Model
Rieko Shimozono, Yoshiji Asaoka, Yoshitaka Yoshizawa, Takumi Aoki, Hidetoshi Noda, Masateru Yamada, Mie Kaino and Hidenori Mochizuki
Molecular Pharmacology July 1, 2013, 84 (1) 62-70; DOI: https://doi.org/10.1124/mol.112.084269
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement